Bengaluru的Cytecare医院现已获得肾移植许可证,增加了在印度获得救生护理的机会。 Cytecare Hospitals in Bengaluru now licensed for kidney transplants, boosting access to life-saving care in India.

印度孟加拉邦的妇科医院已经获得政府批准进行肾移植,扩大了其先进的器官护理服务。 Cytecare Hospitals in Bengaluru, India, has received government approval to perform kidney transplants, expanding its advanced organ care services. 许可证允许医院提供多学科办法,让肾病学、外科和重症护理专家参与。 The license allows the hospital to offer a multidisciplinary approach involving specialists in nephrology, surgery, and critical care. 这一发展增强了有肾病这一印度日益严重的健康问题的终期肾病患者获得救生治疗的机会。 This development enhances access to life-saving treatment for patients with end-stage kidney disease, a growing health issue in India. 医院强调道德实践、病人教育和长期支持,将自己定位为Karnataka移植护理领域的关键提供者。 The hospital emphasizes ethical practices, patient education, and long-term support, positioning itself as a key provider in Karnataka’s transplant care landscape.